Reta (10mg)

Reta (LY3437943) is a potent triple agonist peptide targeting the glucagon receptor (GCGR), glucagon-like peptide-1 receptor (GLP-1R), and glucose-dependent insulinotropic polypeptide receptor (GIPR). It exhibits strong binding affinities with EC₅₀ values of 5.79 nM (GCGR), 0.775 nM (GLP-1R), and 0.0643 nM (GIPR). Due to its multi-receptor activation profile, Reta is a valuable compound for research into metabolic regulation and obesity mechanisms.